Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX2 | P34913 | 3/20 | 0.66 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.61 |
| ▸ | LMNA | P02545 | 3/20 | 0.60 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.60 |
| ▸ | PPARA | Q07869 | 3/20 | 0.51 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.51 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.51 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.51 |
| ▸ | TSHR | P16473 | 1/20 | 0.51 |
| ▸ | HTR2A | P28223 | 1/20 | 0.51 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.51 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.51 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.51 |
| ▸ | POLB | P06746 | 1/20 | 0.49 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.48 |
| ▸ | GAA | P10253 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 2/20 | 0.47 |
| ▸ | PPARG | P37231 | 2/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10022852 | 1.00 | EPHX2 (0.66) | EPHX2KMT2ALMNAL3MBTL1PPARA | |
| SCHEMBL10964710 | 0.95 | EPHX2 (0.62) | EPHX2KMT2ALMNAL3MBTL1PPARA | |
| SCHEMBL11626154 | 0.92 | EPHX2 (0.66) | EPHX2KMT2ALMNAL3MBTL1PPARA | |
| SCHEMBL10703205 | 0.92 | EPHX2 (0.59) | EPHX2KMT2ALMNAL3MBTL1PPARA | |
| SCHEMBL11512491 | 0.91 | EPHX2 (0.58) | EPHX2KMT2ALMNAL3MBTL1PPARA | |
| SCHEMBL23605759 | 0.89 | L3MBTL1 (0.76) | EPHX2KMT2ALMNAL3MBTL1 | |
| SCHEMBL11510461 | 0.89 | L3MBTL1 (0.76) | EPHX2KMT2ALMNAL3MBTL1 | |
| SCHEMBL11516006 | 0.89 | EPHX2 (0.56) | EPHX2KMT2ALMNAL3MBTL1PPARA | |
| SCHEMBL28252830 | 0.87 | EPHX2 (0.53) | EPHX2KMT2ALMNAL3MBTL1PPARA | |
| SCHEMBL21991473 | 0.86 | EPHX2 (0.63) | EPHX2KMT2ALMNAL3MBTL1PPARA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 53 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119306591-A | Method for generating phenoxycarboxylic acid by utilizing acid exchange | 山东润博生物科技有限公司 | 2025-01-14 | — | — | CN | claimed |
| US-20070232492-A1 | Herbicidal Composition | ISHIHARA SANGYO KAISHA, LTD. (JP) | 2007-10-04 | — | — | US | claimed |
| JP-1213201-A | — | — | None | — | — | JP | disclosed |
| JP-56036403-A | — | — | None | — | — | JP | disclosed |
| WO-2025103220-A1 | PYRIDYL ALKOXY PYRIMIDINE COMPOUND AND USE THEREOF | 青岛清原化合物有限公司 | 2025-05-22 | — | — | WO | disclosed |
| CN-119306591-A | Method for generating phenoxycarboxylic acid by utilizing acid exchange | 山东润博生物科技有限公司 | 2025-01-14 | — | — | CN | disclosed |
| CN-117645540-A | Preparation method of chlorophenoxycarboxylate | 山东润博生物科技有限公司 | 2024-03-05 | — | — | CN | disclosed |
| US-20220409566-A1 | CCL5 Inhibitors | LAPKO INC, dba AFECTA PHARMACEUTICALS | 2022-12-29 | — | — | US | disclosed |
| US-20220142961-A1 | CCL5 Inhibitors | LAPKO INC, dba AFECTA PHARMACEUTICALS | 2022-05-12 | — | — | US | disclosed |
| US-11318111-B2 | CCL5 inhibitors | LAPKO INC (US) | 2022-05-03 | — | — | US | disclosed |
| US-20210196665-A1 | CCL5 Inhibitors | AFECTA PHARMACEUTICALS, INC. (US) | 2021-07-01 | — | — | US | disclosed |
| US-4348534-A | Preparation of 2-aryloxy-2-haloproptonic acid compounds | BASF AKTIENGESELLSCHAFT (DE) | 1982-09-07 | — | — | US | disclosed |
| US-4334914-A | PRE-AND POSTEMERGENT APPLICATION | NIHON NOHYAKU CO., LTD. (JP) | 1982-06-15 | — | — | US | disclosed |
| US-4318731-A | Δ2 -1,2,4-triazolin-5-one derivatives and herbicidal usage thereof | NIHON NOHYAKU CO., LTD. (JP) | 1982-03-09 | — | — | US | disclosed |
| EP-0034457-A1 | Benzoate derivative, method of preparing the same and use thereof | NIHON NOHYAKU CO., LTD. (JP) | 1981-08-26 | — | — | EP | disclosed |
| JP-S5636403-A | HERBICIDAL COMPOSITION | HOKKO CHEM IND CO LTD | 1981-04-09 | — | — | JP | disclosed |
| US-4226616-A | A 3-ALKYL- OR -ALKYLOXYETHYLOXY-4-NITRO-2'-CHLORO-4'-TRIFLUOROMETHOXYDIPHENYL ETHER | NIHON NOHYAKU CO., LTD. (JP) | 1980-10-07 | — | — | US | disclosed |
| US-4157256-A | Tetrahydrophthalimide and herbicide containing the same | NIHON NOHYAKU CO. LTD. (JP) | 1979-06-05 | — | — | US | disclosed |
| US-3961935-A | Synergistic herbicidal composition comprising O-methyl or O-ethyl-O-(3-methyl-6-nitrophenyl)-N-secondary-butylphosphorothioamidate and a phenoxy-type herbicide | SUMITOMO CHEMICAL COMPANY, LIMITED (JA) | 1976-06-08 | — | — | US | disclosed |
| JP-S05636403-A | — | — | 0001-01-01 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220142961-A1 | CCL5 Inhibitors | CCL5, CCL11, CCR5 | EPHX2 1344/4885KMT2A 4842/4885LMNA 4533/4885 |
| US-20210196665-A1 | CCL5 Inhibitors | CCL5, CCL11, CCR5 | EPHX2 1344/4885KMT2A 4842/4885LMNA 4533/4885 |
| US-20070232492-A1 | Herbicidal Composition | DDT, SPIN2B, CCNB3 | EPHX2 2256/4885KMT2A 1270/4885LMNA 1003/4885 |
| US-11318111-B2 | CCL5 inhibitors | CCL5, CCL11, CCR5 | EPHX2 1344/4885KMT2A 4842/4885LMNA 4533/4885 |
| US-20220409566-A1 | CCL5 Inhibitors | CCL5, CCL11, CCR5 | EPHX2 1344/4885KMT2A 4842/4885LMNA 4533/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.